CAG Diagnostics capital - instruments — Total Revenue
Idexx Laboratories CAG Diagnostics capital - instruments — Total Revenue decreased by 27.0% to $42.45M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.7%, from $31.99M to $42.45M. Over 4 years (FY 2021 to FY 2025), CAG Diagnostics capital - instruments — Total Revenue shows an upward trend with a 7.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong adoption of the company's diagnostic hardware platform and potential for future recurring consumable sales, while a decrease may signal market saturation or increased competition in the veterinary equipment space.
Detailed definition
This metric represents the total revenue generated from the sale and lease of diagnostic capital equipment, specifically...
Peer comparison
Comparable to capital equipment revenue in medical device or life sciences companies, where hardware sales act as a gateway to high-margin recurring reagent or consumable revenue streams.
idxx_segment_cag_diagnostics_capital_instruments_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.29M | $37.29M | $37.29M | $36.83M | $36.83M | $36.83M | $36.83M | $33.14M | $34.05M | $32.25M | $38.15M | $34.09M | $35.29M | $29.53M | $33.02M | $31.99M | $58.60M | $51.48M | $58.13M | $42.45M |
| QoQ Change | — | +0.0% | +0.0% | -1.2% | +0.0% | +0.0% | +0.0% | -10.0% | +2.7% | -5.3% | +18.3% | -10.6% | +3.5% | -16.3% | +11.8% | -3.1% | +83.2% | -12.2% | +12.9% | -27.0% |
| YoY Change | — | — | — | — | -1.2% | -1.2% | -1.2% | -10.0% | -7.5% | -12.4% | +3.6% | +2.9% | +3.6% | -8.5% | -13.5% | -6.2% | +66.0% | +74.3% | +76.1% | +32.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's cag diagnostics capital - instruments — total revenue?
- Idexx Laboratories (IDXX) reported cag diagnostics capital - instruments — total revenue of $42.45M in Q1 2026.
- How has Idexx Laboratories's cag diagnostics capital - instruments — total revenue changed year-over-year?
- Idexx Laboratories's cag diagnostics capital - instruments — total revenue increased by 32.7% year-over-year, from $31.99M to $42.45M.
- What is the long-term trend for Idexx Laboratories's cag diagnostics capital - instruments — total revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's cag diagnostics capital - instruments — total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $149.14M to $200.21M.
- What does cag diagnostics capital - instruments — total revenue mean?
- Total revenue earned from selling or leasing diagnostic hardware equipment to veterinary clinics.